BioLife Solutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLFS and other ETFs, options, and stocks.

About BLFS

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. 

CEO
Roderick de Greef
CEORoderick de Greef
Employees
155
Employees155
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
1987
Founded1987
Employees
155
Employees155

BLFS Key Statistics

Market cap
1.03B
Market cap1.03B
Price-Earnings ratio
-75.80
Price-Earnings ratio-75.80
Dividend yield
Dividend yield
Average volume
363.62K
Average volume363.62K
High today
$21.30
High today$21.30
Low today
$20.87
Low today$20.87
Open price
$21.28
Open price$21.28
Volume
261.88K
Volume261.88K
52 Week high
$29.62
52 Week high$29.62
52 Week low
$17.86
52 Week low$17.86

Stock Snapshot

BioLife Solutions(BLFS) stock is priced at $21.06, giving the company a market capitalization of 1.03B. It carries a P/E multiple of -75.80.

As of 2026-05-14, BioLife Solutions(BLFS) stock has fluctuated between $20.87 and $21.30. The current price stands at $21.06, placing the stock +0.9% above today's low and -1.1% off the high.

BioLife Solutions(BLFS) shares are trading with a volume of 261.88K, against a daily average of 363.62K.

During the past year, BioLife Solutions(BLFS) stock moved between $17.86 at its lowest and $29.62 at its peak.

During the past year, BioLife Solutions(BLFS) stock moved between $17.86 at its lowest and $29.62 at its peak.

BLFS News

Simply Wall St 3d
How Investors Are Reacting To BioLife Solutions Return To Profitability And Reaffirmed 2026 Outlook

In early May 2026, BioLife Solutions reported first‑quarter 2026 results showing revenue of US$27.5 million versus US$22.05 million a year earlier, with net inc...

How Investors Are Reacting To BioLife Solutions Return To Profitability And Reaffirmed 2026 Outlook
Simply Wall St 5d
A Look At BioLife Solutions Valuation After Its Recent Share Price Rebound

Advertisement Why BioLife Solutions Stock Is on Investors’ Radar BioLife Solutions (BLFS) has drawn fresh attention after a recent stretch of positive returns...

A Look At BioLife Solutions Valuation After Its Recent Share Price Rebound
TipRanks 6d
BioLife Solutions Earnings Call Highlights Growth Path

BioLife Solutions Inc ((BLFS)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data a...

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own BLFS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.